STOCK TITAN

Charles Schwab insider files Form 144 to sell 50,016 shares valued at $4.85M

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

The filing notifies a proposed sale of 50,016 shares of The Charles Schwab Corporation common stock with an aggregate market value of $4,852,552.00. The shares are scheduled for sale on the NYSE on 08/27/2025. The filing shows the shares were acquired the same day, 08/27/2025, via a stock option granted by the issuer and paid on that date. No other sales by the reporting person were reported in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.

Positive

  • Compliance disclosure filed: the Form 144 provides required details (shares, value, broker, exchange, acquisition type) for Rule 144 transparency
  • No sales in prior three months reported by the person, which limits signals of an ongoing large disposal program

Negative

  • None.

Insights

TL;DR: Routine Rule 144 notice for an insider sale of 50,016 Schwab shares valued at ~$4.85M; procedural disclosure with no other recent sales.

This Form 144 presents a standard, compliance-focused disclosure of a proposed sale under Rule 144. Key datapoints are the quantity, $4.85M aggregate value, and the planned sale date. The acquisition via stock option and same-day payment are explicitly stated, suggesting a routine exercise-and-sell transaction often used for liquidity by option holders. Absence of other sales in the prior three months reduces immediate signal of ongoing disposal activity. No additional operational or financial information about the issuer is included, limiting investor inference.

TL;DR: Governance disclosure appears complete for Rule 144 purposes; statement attesting no undisclosed material information is included.

The form includes the required attestation that the seller is unaware of undisclosed material adverse information, and lists acquisition type as an issuer-granted stock option. From a governance perspective, the filing meets procedural requirements: it identifies the class, broker, quantity, aggregate value, exchange, and acquisition details. The filing does not disclose the reporting person's identity or relationship to the issuer in the visible content, which limits contextual governance assessment.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for SCHW report?

The filing reports a proposed sale of 50,016 common shares of The Charles Schwab Corporation valued at $4,852,552.00, to be sold on 08/27/2025 on the NYSE.

How were the 50,016 Schwab shares acquired?

The shares were acquired on 08/27/2025 via a stock option granted by the issuer, with payment recorded on the same date.

Does the Form 144 show prior sales by the reporting person?

The filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Which broker and exchange are listed for the proposed sale?

The broker listed is The Charles Schwab Corporation, 3000 Schwab Way, Westlake TX and the sale is planned on the NYSE.

Does the filing include an attestation about material information?

Yes, the signer represents they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.